Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000065

EVP Research sold 7,176 shares at an average $32.84 ($235,678)

  • EVP Research acquired 19,160 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Swayze Eric · EVP Research

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-15 Exercise or conversion : show line 1 in the form +19,111 52,824 D
2025-01-16 Sale : show line 2 in the form −7,154 $32.84 $234,959 45,670 D
2025-01-15 Exercise or conversion : show line 3 in the form +49 206 I
2025-01-16 Sale : show line 4 in the form −22 $32.70 $719 184 I
Open-market sales · 7,176 sh · avg $32.84 · $235,678

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2025-01-15 Grant or award : show line 5 in the form Performance Restricted Stock Units +22,000 64,482 D
2025-01-15 Grant or award : show line 6 in the form Restricted Stock Unit +33,000 79,728 D
2025-01-15 Exercise or conversion : show line 7 in the form Restricted Stock Unit −19,111 60,617 D
2025-01-15 Grant or award : show line 8 in the form Restricted Stock Unit +245 671 I
2025-01-15 Exercise or conversion : show line 9 in the form Restricted Stock Unit −49 622 I
Loading xslF345X05/edgardoc.xml…